IL17A and metabolic syndrome: Metabolic syndrome-related and insulin resistance-related dyslipidemia, indicated by increased triglycerides and decreased HDL cholesterol, were positively associated only with the marker IL-37, while on the contrary, the markers NLR and IL-17A were higher when there were no signs of metabolic syndrome.